Danaher Corp (NYSE:DHR)
| 232.24 Delayed Data As of May 26 |  +1.79 / +0.78%Today’s Change | 221.22 Today|||52-Week Range 303.82 | -12.50% Year-to-Date |
Latest DHR News | Press Releases
| Danaher (DHR) Gains But Lags Market: What You Should Know May 26 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 230.45 |
| Today’s open | 231.71 |
| Day’s range | 231.38 - 233.79 |
| Volume | 2,802,884 |
| Average volume (3 months) | 2,890,702 |
| Market cap | $171.3B |
Data as of 4:00pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | +11.66% |
| Earnings growth (this year) | -13.78% |
| Earnings growth (next 5 years) | +9.00% |
| Revenue growth (last year) | +6.85% |
| P/E ratio | 25.0 |
| Price/Sales | 6.22 |
| Price/Book | 3.49 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TMOThermo Fisher Scient... | +1.33 | +0.26% |
| AAgilent Technologies... | +0.92 | +0.77% |
| MTDMettler-Toledo Inter... | +31.98 | +2.43% |
| WATWaters Corp | +0.97 | +0.37% |
Data as of 3:59pm ET, 05/26/2023
Financials
| Next reporting date | July 20, 2023 |
| EPS forecast (this quarter) | $2.04 |
| Annual revenue (last year) | $31.5B |
| Annual profit (last year) | $7.2B |
| Net profit margin | 22.91% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Washington, District Of Columbia |
Forecasts
